Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de las Nieves (31)

2024

  1. Early heart and skeletal muscle mitochondrial response to a moderate hypobaric hypoxia environment

    Journal of Physiology

  2. Using Redox Proteomics to Gain New Insights into Neurodegenerative Disease and Protein Modification

    Antioxidants, Vol. 13, Núm. 1

2023

  1. A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in surgical patients with severe sepsis admitted to the intensive care unit

    Journal of Pineal Research, Vol. 74, Núm. 2

2022

  1. Salivary Melatonin Rhythm and Prostate Cancer: CAPLIFE Study

    Journal of Urology, Vol. 207, Núm. 3, pp. 565-572

2021

  1. Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

    Nature Communications, Vol. 12, Núm. 1

  2. Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage

    Nature Communications, Vol. 12, Núm. 1

2020

  1. Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information

    Nature Communications, Vol. 11, Núm. 1

2019

  1. Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset

    npj Parkinson's Disease, Vol. 5, Núm. 1

  2. Modulation by sigma-1 receptor of morphine analgesia and tolerance: Nociceptive pain, tactile allodynia and grip strength deficits during joint inflammation

    Frontiers in Pharmacology, Vol. 10, Núm. FEB

  3. Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability

    npj Parkinson's Disease, Vol. 5, Núm. 1

  4. SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease

    Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344

  5. The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight

    Movement Disorders, Vol. 34, Núm. 12, pp. 1851-1863

2018

  1. Modality-specific peripheral antinociceptive effects of μ-opioid agonists on heat and mechanical stimuli: Contribution of sigma-1 receptors

    Neuropharmacology, Vol. 135, pp. 328-342

  2. Targeting immune-driven opioid analgesia by sigma-1 receptors: Opening the door to novel perspectives for the analgesic use of sigma-1 antagonists

    Pharmacological Research, Vol. 131, pp. 224-230

2017

  1. Effects of tetrodotoxin in mouse models of visceral pain

    Marine Drugs, Vol. 15, Núm. 6

  2. Grip strength in mice with joint inflammation: A rheumatology function test sensitive to pain and analgesia

    Neuropharmacology, Vol. 125, pp. 231-242

  3. Molecular and Functional Characterization of a Cohort of Spanish Patients with Ataxia-Telangiectasia

    NeuroMolecular Medicine, Vol. 19, Núm. 1, pp. 161-174

  4. Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Núm. 31, pp. 8396-8401

2016

  1. Analysis of the genetic variability in Parkinson's disease from Southern Spain

    Neurobiology of Aging, Vol. 37, pp. 210.e1-210.e5

  2. Genome-wide assessment of Parkinson's disease in a Southern Spanish population

    Neurobiology of Aging, Vol. 45, pp. 213.e3